Moxifloxacin
NDC Package 0591-3957-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Moxifloxacin is a medication a quinolone antibiotic used for eye infections. Marketed by Actavis Pharma, Inc., this product is identified by NDC 0591-3957 and is authorized under FDA application ANDA202525.

Identification & Billing

NDC Package Code
0591-3957-03
Package Description
1 BOTTLE, DROPPER in 1 CARTON / 3 mL in 1 BOTTLE, DROPPER
Product Code
0591-3957
11-Digit Billing Format
00591395703

Clinical Specifications

Proprietary Name
Moxifloxacin
Dosage Form
-
Usage Information
This medication is a quinolone antibiotic used for eye infections.

Regulatory & Marketing

Labeler Name
Actavis Pharma, Inc.
FDA Application #
ANDA202525
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-31-2019
End Marketing Date
12-31-2019
Listing Expiration
12-31-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0591-3957-03 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 3 ml in 1 bottle, dropper of Moxifloxacin, labeled by Actavis Pharma, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Actavis Pharma, Inc. on December 31, 2019. The current certification is valid through December 31, 2019.

What are the primary indications for this medication?

This medication is a quinolone antibiotic used for eye infections.

How is this Actavis Pharma, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00591395703. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0591-3957-03
11-Digit CMS (5-4-2)
00591-3957-03

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.